Fri, Aug 22, 2014, 11:03 AM EDT - U.S. Markets close in 4 hrs 57 mins

Recent

% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • stupid_hobo73 stupid_hobo73 Mar 20, 2012 1:05 PM Flag

    supreme court decision news

    GHDX is trading down in sympathy with today's news but it really is just in sympathy.....GHI does not patent genes....they patent algorithms...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • As I read the decision, this ruling directly impacts the current patents of GHDX. The ruling is that you can not patent the observation of a correlation between natural phenomena to use to make diagnostic recommendations. That is exactly GHDX's business.

      Consider this account of the oral arguments and see if it sounds similar to you:

      A patient, he posited, has a headache, and takes aspirin for it. An “amazing thing” happens: by looking at the patient’s little finger, one notices that it is changing color. If it is one color, a doctor concludes, the patient took too little aspirin, but if it is a different color, the conclusion is that the patient got too much. “Now,” suggested Breyer, “I’ve discovered a law of nature and I may have spent millions on that. And I can’t patent that law of nature.”

      • 2 Replies to flazney
      • Wonder if that concerns Felix and Julian.
        Obviously not.

      • http://www.supremecourt.gov/opinions/11pdf/10-1150.pdf

        Unfortunately, I believe there may be some room for misinterpretation and, so, this ruling could give GH some headaches. But my reading of this would allow for GH to claim sufficient invention with their products.

        See pp 12 and 13. The discussion of Flook and Diehr. GH's patents "explain how the variables used in the equations are to be selected.". There is "inventive concept" in the methods of finding and associating the "laws of nature" (in our case, genomes) with the nature of one's illness.

        Prometheus used one formula of a known natural process, suggested values on which to make decisions, and objected when Mayo suggested their own different values. Mayo has a right to advance scientific knowledge using that well known law of nature.

        If Mayo went to the trouble of identifying genomes associated with breast cancer, including any "discovered" by GH, and back tested them to find their own algorithm that predicted something useful in treatment decisions, and THEN tested that algorithm against real cases so that they gained FDA approval, then GH would have no claim against them. (at least, that is how I read this decision). But that is a hurdle sufficiently high.

        ford

 
GHDX
28.16+0.08(+0.28%)11:02 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.